The Pan-American Journal of Ophthalmology (Jan 2021)

Choroidal osteoma with choroidal neovascularization treated with bevacizumab in a young male patient

  • Jorge Henrique Cavalcante Tavares,
  • Guilherme Sturzeneker,
  • Melina Correia Morales,
  • Rubens N Belfort

DOI
https://doi.org/10.4103/pajo.pajo_58_20
Journal volume & issue
Vol. 3, no. 1
pp. 6 – 6

Abstract

Read online

The purpose of the study is to report a case of choroidal neovascularization (CNV) related to choroidal osteoma treated with intravitreal injections of bevacizumab. This was a case report in which antivascular endothelial growth factor intravitreal injections were used to treat choroidal osteoma-related CNV. A 27-year-old man with a history of blurred vision in his left eye for 15 days presented best-corrected visual acuity (BCVA) of 20/60. Fundus examination, ultrasonography, fluorescein angiography, and optical coherence tomography revealed a nasal and superior juxtapapillary choroidal osteoma with a choroidal neovascular membrane, associated with serous retinal detachment affecting the macula. After three intravitreal injections of bevacizumab, the patient improved to a BCVA of 20/30 and partial resolution of subretinal fluid. Choroidal osteoma with CNV may present a good response to bevacizumab therapy.

Keywords